Northeast Pharmaceutical announced on October 9 the appointment of Wang Weilin and Li Li as deputy general managers, with terms starting from the date of approval by the board of directors and ending upon the expiration of the tenth board. In the first half of 2026, Northeast Pharmaceutical achieved revenue of 3.333 billion yuan and net profit attributable to the parent of 83.86 million yuan.
Northeast Pharmaceutical Group Co LtdAppointment of two deputy general managers is a routine management change with no clear financial driver; revenue and profit figures are only reported as context.
